AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. The company is dedicated to enabling users to take control of their heart health.
Atomwise develops artificial intelligence systems for drug discovery. Its groundbreaking research technology learns like a human chemist, using powerful deep neural networks and supercomputers to analyze millions of potential medicines each day. Atomwise deploys its discovery platform to predict both new and repurposed drug candidates for pharmaceutical companies, biotechnology startups and research institutions.
Carrot Sense aims to engage and empower millions of people to quit smoking.
Catalia Health is on a mission to address both sides of the healthcare equation: improving patients’ health and extending the capabilities and efficiency of healthcare companies. The company aims to catalyze lasting behavior change for patients, wherever they are, to provide them with encouragement and motivation to achieve the best possible medical outcomes. At the same time, Catalia Health is providing deep insights to healthcare companies to optimize the efficacy of their services. Catalia Health believes that to improve behavior, you have to measure it—and keep measuring it over the long term.
CellScope builds systems for at-home disease diagnosis using smartphone cameras connected to a web platform. The company’s mission is to create the world’s first smartphone-enabled digital first aid kit, giving access to easy-to-use, at-home tools in order to capture diagnostic-quality data for remote diagnosis. CellScope is currently building a suite of optical attachments for smartphones.
Color provides accessible, population-scale genetics services. Color analyzes 19 genes to help you understand your risk of developing breast and ovarian cancer.
Consumer Physics is building a pocket spectrometer for smart phones, enabling a variety of consumer applicatons. Their first product, SCiO, reads the chemical make-up of materials; it is a non-intrusive, no-touch optical sensor that provides a seamless user experience.
CrossChx is the only global solution to the healthcare identity crisis. CrossChx’s proprietary identity resolution system and intelligence solutions help healthcare providers drive revenue, reduce risk, and improve health outcomes.
CrowdMed uses prediction market technology and the collective intelligence of human ‘medical detectives’ to produce diagnostic suggestions.
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics that enables precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.